These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20034801)

  • 1. New thalidomide analogues derived through Sonogashira or Suzuki reactions and their TNF expression inhibition profiles.
    Stewart SG; Braun CJ; Ng SL; Polomska ME; Karimi M; Abraham LJ
    Bioorg Med Chem; 2010 Jan; 18(2):650-62. PubMed ID: 20034801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross coupling.
    Stewart SG; Spagnolo D; Polomska ME; Sin M; Karimi M; Abraham LJ
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5819-24. PubMed ID: 17851074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production.
    Miyachi H; Azuma A; Hioki E; Iwasaki S; Kobayashi Y; Hashimoto Y
    Biochem Biophys Res Commun; 1996 Jul; 224(2):426-30. PubMed ID: 8702405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.
    Chaulet C; Croix C; Alagille D; Normand S; Delwail A; Favot L; Lecron JC; Viaud-Massuard MC
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1019-22. PubMed ID: 21215621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues.
    Bradshaw M; Rutherford MS; Hoeper BJ; McWhinney CD; Borcherding DR; Schook LB; Edwards CK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1506-18. PubMed ID: 7791126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell type-/inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production and its enantio-dependence.
    Miyachi H; Azuma A; Hioki E; Iwasaki S; Kobayashi Y; Hashimoto Y
    Biochem Biophys Res Commun; 1996 Sep; 226(2):439-44. PubMed ID: 8806653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to the anti-TNF-alpha drug thalidomide induces apoptotic cell death in human T leukemic cells.
    Ezell TN; Maloney N; Githua JW; Taylor LD
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1117-24. PubMed ID: 14682394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering a new analogue of thalidomide which may be used as a potent modulator of TNF-alpha production.
    Fernández Braña M; Acero N; Añorbe L; Muñoz Mingarro D; Llinares F; Domínguez G
    Eur J Med Chem; 2009 Sep; 44(9):3533-42. PubMed ID: 19394719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
    Lin YC; Shun CT; Wu MS; Chen CC
    Clin Cancer Res; 2006 Dec; 12(23):7165-73. PubMed ID: 17145842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.
    Alexandre-Moreira MS; Takiya CM; de Arruda LB; Pascarelli B; Gomes RN; Castro Faria Neto HC; Lima LM; Barreiro EJ
    Int Immunopharmacol; 2005 Mar; 5(3):485-94. PubMed ID: 15683845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide and its analogues inhibit lipopolysaccharide-mediated Iinduction of cyclooxygenase-2.
    Fujita J; Mestre JR; Zeldis JB; Subbaramaiah K; Dannenberg AJ
    Clin Cancer Res; 2001 Nov; 7(11):3349-55. PubMed ID: 11705847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
    Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
    Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide.
    Settles B; Stevenson A; Wilson K; Mack C; Ezell T; Davis MF; Taylor LD
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1105-14. PubMed ID: 11838958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum.
    Ferger B; Leng A; Mura A; Hengerer B; Feldon J
    J Neurochem; 2004 May; 89(4):822-33. PubMed ID: 15140182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antiinflammatory activity of novel phthalimide derivatives, structurally related to thalidomide.
    Machado AL; Lima LM; Araújo JX; Fraga CA; Koatz VL; Barreiro EJ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1169-72. PubMed ID: 15686935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats.
    Lopez-Talavera JC; Cadelina G; Olchowski J; Merrill W; Groszmann RJ
    Hepatology; 1996 Jun; 23(6):1616-21. PubMed ID: 8675185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors.
    Lepper ER; Ng SS; Gütschow M; Weiss M; Hauschildt S; Hecker TK; Luzzio FA; Eger K; Figg WD
    J Med Chem; 2004 Apr; 47(9):2219-27. PubMed ID: 15084120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid.
    Cao Z; Joseph WR; Browne WL; Mountjoy KG; Palmer BD; Baguley BC; Ching LM
    Br J Cancer; 1999 May; 80(5-6):716-23. PubMed ID: 10360649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
    Goto M; Yamada K; Katayama K; Tanaka I
    Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.